US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 5.710
  • +0.350+6.53%
Trading Apr 24 12:18 ET
34.91MMarket Cap-0.27P/E (TTM)

Aligos Therapeutics Key Stats

Aligos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 333.330K--
--2025/Q1-- / 333.330K--
Mar 10, 20252024/Q4629.000K / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 333.330K--
--2025/Q1-- / 333.330K--
Mar 10, 20252024/Q4629.000K / 433.330K--
Nov 6, 20242024/Q31.269M / 333.330K--
Aug 6, 20242024/Q21.061M / 0.000--

Unlock Free Earnings Estimates

Aligos Therapeutics Earnings Reports

Read more

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More